7 nominees · 6 ballot items.
Stockholders will vote on the election of seven directors, approval of the Series D and warrant share issuance, expansion of the 2024 equity plan, increases in authorized common and preferred shares, auditor ratification, and authorization to adjourn the meeting if needed.
Elect seven nominees to serve as directors until the 2027 annual meeting of stockholders or until their successors are elected and qualified.
Approve potential issuance of common stock upon conversion of the Series D Convertible Preferred Stock and exercise of the related warrant in excess of Nasdaq limitations, including the 19.99% cap under Nasdaq Listing Rule 5635(d).
Proposal 2 asks stockholders to authorize issuance of common shares underlying the Series D Convertible Preferred Stock and the related warrant beyond the 19.99% exchange cap and other limits imposed by Nasdaq Listing Rule 5635(d). The securities were issued in a June 30, 2026 private placement to Six Thirty AI, LLC for gross proceeds of $15.03 million, together with a five-year warrant for 926,748 shares. The Series D has a floating conversion price subject to a $1.80 floor, while the warrant has an exercise price of $10.81. Without approval, the transaction documents would continue to restrict aggregate issuances to 19.99% of the pre-transaction outstanding common stock. Approval would allow the Company to issue potentially up to the shares covered by the registration statement, including shares associated with accrued PIK dividends, subject to other ownership and monthly conversion restrictions. The Company warns that approval could materially dilute existing holders and increase shares available for resale, potentially pressuring the stock price. If approval is withheld, the preferred stock and warrant remain outstanding, dividends continue accruing, and the Company may face redemption, covenant, and cash-use constraints. The Purchaser is controlled by Executive Chair Joshua Kilgore, CEO Phillip Stanley, and COO Cody Smith, making the transaction particularly significant from a related-party and governance perspective. A special transactions committee of disinterested directors and the Audit Committee reviewed and approved the transaction. The Board unanimously recommends a vote FOR, principally to remove the issuance restriction and preserve flexibility under the financing.
Approve an amended and restated 2024 Omnibus Equity Incentive Plan that increases the authorized share reserve by 1,000,000 shares.
Proposal 3 asks stockholders to approve an amended and restated 2024 Omnibus Equity Incentive Plan. The amendment would add 1,000,000 shares to the plan’s authorized reserve, increasing the total stated reserve to 1,500,000 shares before other recycling and evergreen provisions. Management says approximately 425,827 shares remain available and expects the existing reserve to be exhausted in 2026 or 2027. The Company argues that equity awards are important for attracting, retaining, and motivating employees, consultants, and non-employee directors in a rapidly changing digital-infrastructure business. It also contends that replacing equity compensation with cash would increase operating expenses and negative cash flow, potentially reducing funds available for capital projects. The proposed reserve is expected to support equity awards for approximately two to three years, although actual usage will depend on business conditions, stock price, hiring, and retention needs. The plan includes governance protections such as independent administration, minimum exercise prices for options and stock appreciation rights, limited transferability, and clawback provisions. The plan also contains an evergreen provision allowing annual increases of up to 250,000 shares through the plan’s ten-year term, subject to Board determination. The additional reserve could produce meaningful dilution because the Company has only 5,718,050 common shares outstanding as of the record date. The Board nevertheless determined the increase was appropriate and unanimously recommends a vote FOR.
Approve an amendment to increase authorized common stock from 90,000,000 to 200,000,000 shares and authorized preferred stock from 1,000,000 to 2,000,000 shares.
Proposal 4 asks stockholders to amend the Certificate of Incorporation to increase authorized common shares from 90 million to 200 million and authorized preferred shares from 1 million to 2 million. The proposed amendment would give the Board authority to issue additional shares without further stockholder approval, subject to applicable law, Nasdaq rules, and existing contractual rights. Management states that only 5,718,050 common shares were outstanding as of September 14, 2026, while 100,000 preferred shares had been designated as Series D and 16,400 Series D shares were outstanding. The Company says the additional capacity is prudent because it expects to need external financing for working capital and business development. Potential uses include capital raising, equity incentives, strategic relationships, acquisitions, and other corporate purposes. Management says it currently has no specific plans, agreements, or understandings for issuing the additional authorized shares. The principal shareholder concern is dilution of earnings per share, book value per share, voting power, and percentage ownership. The availability of preferred shares could also permit future designations with special rights, subject to Series D holder protections and other approval requirements. The expanded authorization could have anti-takeover effects by enabling defensive issuances that make a change in control more difficult or expensive. The Board unanimously recommends a vote FOR, emphasizing financing and corporate flexibility while acknowledging potential dilution and takeover-related risks.
Ratify the Audit Committee’s appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Authorize the Board to adjourn the Annual Meeting, including to solicit additional proxies, if necessary or appropriate due to insufficient votes on the other proposals.
Proposal 6 asks stockholders to authorize the Board to adjourn the Annual Meeting if necessary or appropriate. The stated purpose is to provide additional time to solicit proxies when there are insufficient votes to approve one or more of the other proposals. An adjournment could occur even after proxies opposing the proposals have been received, allowing the Company to seek to persuade those stockholders to change their votes. Stockholders who have already submitted proxies would retain the ability to revoke them before the proxies are used. The proposal is procedural rather than substantive and does not itself approve the Series D financing, equity plan, authorized-share increase, or any other underlying matter. Its practical effect is to preserve management’s ability to continue solicitation and defer voting if the meeting lacks sufficient support. Because the proposal is treated as routine under the filing’s voting discussion, brokers may have authority to vote uninstructed shares. Approval requires a majority of votes cast, with abstentions described as having no effect on the outcome. The Board unanimously recommends a vote FOR, primarily to avoid an unsuccessful or prematurely concluded meeting caused by insufficient votes.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC | 1.03% | 58,262 | $520K |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 0.81% | 45,621 | $407K |
| 3 | NewEdge Advisors, LLC | 0.67% | 37,983 | $339K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.60% | 33,868 | $302K |
| 5 | UBS Group AG | 0.45% | 25,500 | $227K |
| 6 | BLUEFIN CAPITAL MANAGEMENT, LLC | 0.45% | 25,338 | $226K |
| 7 | VANGUARD FIDUCIARY TRUST CO | 0.37% | 21,051 | $188K |
| 8 | Chicago Partners Investment Group LLC | 0.31% | 17,700 | $99K |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.24% | 13,455 | $120K |
| 10 | STATE STREET CORP | 0.21% | 11,800 | $105K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.